XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.54−0.08 (-4.94%)
Close on Nov 18, 2026Market cap $14.57MP/E –Yield –
XTL Biopharmaceuticals net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2015 it was $2.00K.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $2.00K | – |
See a number that looks wrong?